Second Edition of International NASH Day Announced Under a New Coalition Leadership
WASHINGTON, Feb. 13, 2019 /PRNewswire/ -- International NASH Day, a public education campaign launched by The NASH Education Program in June 2018 to raise visibility and urgency around fatty liver disease and its more advanced form, nonalcoholic steatohepatitis (NASH) which affect more than 115 million people around the world, will be led by a consortium of patient advocacy organizations medical and professional societies, spearheaded by the Global Liver Institute.
Originally established and led by The NASH Education Program, a Genfit initiative, to address a now widely recognized gap in educational resources for physicians and patients on this growing public health epidemic, International NASH Day coordinated over 50 events from liver health screenings, policy briefings, and education events online and in more than 25 cities across the globe on and around June 12, 2018. "After the large success of the first International NASH Day, which has had a real impact on different stages across the world, we have been looking for the best global partners to take over and grow this initiative," says Pascaline Clerc, US campaign manager for The NASH Education Program. "We are thrilled to see dedicated community-driven leadership taking over the initiative who can count on Genfit's and the NASH Education Program's support. It is our mission to promote awareness and education on this silent and widespread disease, and we will continue to do so by encouraging the initiatives undertaken by the new consortium, further reinforcing our commitment to better serve patients' needs."
The newly formed consortium will collaborate on strategic direction for the International NASH Day efforts, with the Global Liver Institute providing day-to-day management of the Consortium. Significant expansions of the consortium as well as the Scientific and Corporate Advisory groups are anticipated.
Global Liver Institute CEO Donna Cryer, a liver transplant recipient, explains, "Fatty liver disease and NASH are impending public health epidemics that have gone virtually unrecognized and untreated, leading to unnecessary patient and family suffering and death. We are grateful that International NASH Day was started, and feel confident that under the leadership of the global liver advocacy community this initiative will continue to grow into a high-profile, high-impact movement sustained by the public, policymakers, clinicians, researchers, and patients around the world."
In 2019, International NASH Awareness Day will be held again on June 12th.
For more information contact firstname.lastname@example.org.
About International NASH Day
International NASH Day is dedicated to increase awareness about non-alcoholic steatohepatitis, or NASH, toward various populations: general public, patients at risk, medical community, public health authorities, medias and much more. To learn more, visit https://www.international-nash-day.com/
About The NASH Education Program™
The non-profit NASH Education Program™ defines and drives initiatives in collaboration with an independent scientific committee composed of four international key opinion leaders in the hepatic and metabolic disease ecosystems in the U.S. and Europe. To learn more, visit www.the-nash-education-program.com.
The Global Liver Institute is a 501(c)(3) tax-exempt not-for-profit organization, headquartered in Washington, D.C., United States. GLI's vision is for liver health to take its place on the global public health agenda commensurate with its prevalence and impact. GLI's mission is to improve the impact of the liver community by promoting innovation, collaboration, and scaling optimal approaches to eradicating liver diseases.
The NASH Education Program™, email@example.com
Global Liver Institute, firstname.lastname@example.org
View original content to download multimedia:http://www.prnewswire.com/news-releases/second-edition-of-international-nash-day-announced-under-a-new-coalition-leadership-300794975.html
SOURCE The NASH Education Program and Global Liver Institute